Statera Biopharma, Inc.
OTC: STAB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Blake Hawley
- Employees
- 46
- Headquarters
- Fort Collins, United States
- IPO year
- 2021
- Market cap
- $7.1K
- Website
- https://www.staterabiopharma.com
Loading STAB…
Loading profile data…Frequently asked questions about STAB
What does Statera Biopharma, Inc. (STAB) do?
Statera BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on developing cutting-edge immunotherapies. These novel treatments aim to address a range of serious conditions, including autoimmune disorders, neutropenia, anemia, emerging viral infections, and various cancers. This development is underpinned by a proprietary techno...
Where does STAB trade?
Statera Biopharma, Inc. (STAB) trades on the Other OTC.
What sector is STAB in?
Statera Biopharma, Inc. (STAB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Statera Biopharma, Inc.?
Blake Hawley is the chief executive officer of Statera Biopharma, Inc. (STAB).
Where is Statera Biopharma, Inc. headquartered?
Statera Biopharma, Inc. is headquartered in United States.
Does STAB pay a dividend?
Statera Biopharma, Inc. (STAB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did STAB go public?
Statera Biopharma, Inc. (STAB) completed its initial public offering in 2021.